Expleo Solutions Stock Screener | Share Price & Fundamental Analysis
EXPLEOSOL
IT Enabled Services
Share Price NSE
₹746.70
▲
25.30 (3.51%)
Share Price BSE
₹745.55
▲
22.60 (3.13%)
Track Expleo Solutions share price live with TickJournal's free stock screener.
Analyze Expleo Solutions share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Expleo Solutions Market Cap
₹1,118.74 Cr.
EXPLEOSOL P/E Ratio (TTM)
10.31
Expleo Solutions P/B Ratio
1.56
EPS (TTM)
₹66.52
Dividend Yield
7.07%
Debt to Equity
0.04
EXPLEOSOL 52 Week High
₹1333.00
Expleo Solutions 52 Week Low
₹646.90
Operating Margin
10.00%
Profit Margin
7.59%
EXPLEOSOL Revenue (TTM)
₹290.00
EBITDA
₹40.00
Net Income
₹22.00
Total Assets
₹831.00
Total Equity
₹636.00
Expleo Solutions Share Price History - Stock Screener Chart
Screen EXPLEOSOL historical share price movements with interactive charts. Analyze price trends and patterns.
Expleo Solutions Company Profile - Fundamental Screener
Screen Expleo Solutions company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for EXPLEOSOL shares.
Sector
Information Technology
Industry
IT Enabled Services
Sub-Sector
IT Enabled Services
Segment
E
ISIN
INE201K01015
Expleo Solutions Balance Sheet Screener
Screen EXPLEOSOL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 831 | 765 | 730 | 594 | 264 | 214 | 192 | 191 | 171 | 182 |
| Current Assets | 563 | 598 | 553 | 449 | 226 | 177 | 163 | 163 | 138 | 153 |
| Fixed Assets | 113 | 131 | 142 | 108 | 25 | 26 | 19 | 22 | 27 | 25 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 51 | 50 | 32 | 25 | 8 | 8 | 1 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 636 | 611 | 530 | 395 | 202 | 152 | 139 | 129 | 127 | 109 |
| Share Capital | 16 | 16 | 16 | 16 | 10 | 10 | 11 | 11 | 11 | 11 |
| Reserves & Surplus | 620 | 596 | 515 | 379 | 192 | 142 | 128 | 118 | 116 | 98 |
Expleo Solutions Income Statement Screener - Profit & Revenue Analysis
Screen Expleo Solutions income statement and profit fundamentals.
Analyze EXPLEOSOL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Expleo Solutions share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 290 | 295 | 267 | 260 | 260 | 272 | 254 | 257 | 262 | 236 | 226 | 227 | 235 | 254 | 220 |
| Expenses | 250 | 236 | 230 | 216 | 219 | 217 | 213 | 221 | 212 | 200 | 194 | 192 | 188 | 168 | 178 |
| EBITDA | 40 | 59 | 37 | 45 | 41 | 55 | 41 | 36 | 50 | 36 | 32 | 35 | 47 | 86 | 43 |
| Operating Profit % | 10.00% | 17.00% | 11.00% | 16.00% | 15.00% | 16.00% | 15.00% | 13.00% | 15.00% | 14.00% | 14.00% | 15.00% | 19.00% | 30.00% | 19.00% |
| Depreciation | 7 | 7 | 8 | 8 | 12 | 10 | 9 | 9 | 8 | 8 | 8 | 8 | 7 | 7 | 7 |
| Interest | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Profit Before Tax | 32 | 51 | 28 | 36 | 28 | 45 | 31 | 26 | 41 | 27 | 24 | 26 | 39 | 77 | 36 |
| Tax | 10 | 12 | 8 | 11 | 9 | 9 | 7 | 11 | 7 | 6 | 5 | 6 | 10 | 22 | 12 |
| Net Profit | 22 | 40 | 20 | 24 | 20 | 36 | 24 | 16 | 34 | 21 | 18 | 20 | 29 | 55 | 24 |
| EPS | 14.26 | 25.62 | 13.16 | 15.51 | 12.75 | 22.86 | 15.40 | 10.12 | 21.93 | 13.22 | 11.88 | 13.01 | 18.73 | 35.67 | 15.44 |
Expleo Solutions Cash Flow Screener - Liquidity Fundamentals
Screen EXPLEOSOL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 179 | 71 | 23 | 24 | 66 | 17 | 41 | 25 | 42 | 58 |
| Investing Activities | -51 | -33 | -37 | 3 | -44 | -7 | 24 | -18 | -14 | 11 |
| Financing Activities | -87 | -15 | -7 | -10 | -3 | -29 | -26 | -31 | -31 | -39 |
| Net Cash Flow | 41 | 24 | -21 | 17 | 19 | -19 | 38 | -23 | -2 | 30 |
Expleo Solutions Shareholding Pattern Screener
See Expleo Solutions shareholding pattern with promoter, FII, and DII holdings.
Check Expleo Solutions promoter holding and ownership changes for EXPLEOSOL on TickJournal.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 71.05% | 71.05% | 71.05% | 71.05% | 71.05% | 71.05% | 71.05% | 71.05% |
| FII Holding | 0.32% | 0.13% | 0.10% | 0.33% | 0.49% | 0.21% | 0.06% | 0.04% |
| DII Holding | 0.07% | 0.84% | 0.84% | 0.91% | 1.00% | 1.78% | 1.83% | 2.37% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 23.07% | 22.60% | 22.58% | 22.02% | 21.21% | 21.12% | 21.37% | 20.91% |
| Other Holding | 5.50% | 5.39% | 5.44% | 5.70% | 6.25% | 5.84% | 5.69% | 5.64% |
| Shareholder Count | 29,158 | 29,017 | 28,491 | 28,556 | 27,530 | 28,506 | 29,083 | 29,462 |
Expleo Solutions Share Dividend Screener - Share Yield Analysis
Check Expleo Solutions dividend history with payout and yield data.
View Expleo Solutions dividend details including ex-dates and amounts for EXPLEOSOL stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹50.00 | 7.73% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹5.00 | 0.41% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹24.00 | 4.74% |
| 2017-March | ₹24.00 | 4.96% |
Expleo Solutions Stock Index Membership
See which indices include Expleo Solutions stock.
Check EXPLEOSOL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE IT
BSE INDEX SMLCAP
Expleo Solutions Market Events Screener - Corporate Actions
Get Expleo Solutions corporate actions including splits, bonuses, and buybacks.
Check Expleo Solutions stock events that may affect EXPLEOSOL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-02-03 | 2026-02-03 | Quarterly Result Announcement | NA | -1.46% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -2.28% |
| 2025-08-21 | 2025-08-21 | Annual General Meeting | NA | -19.23% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -1.54% |
| 2025-05-22 | 2025-05-22 | Quarterly Result Announcement | NA | 4.91% |
| 2025-02-12 | 2025-02-12 | Dividend | ₹ 50.00 /share | -1.71% |
| 2025-02-06 | 2025-02-06 | Quarterly Result Announcement | NA | 1.48% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -2.52% |
| 2024-08-29 | 2024-08-29 | Annual General Meeting | NA | 5.07% |
| 2023-07-14 | 2023-07-14 | Dividend | ₹ 5.00 /share | 3.72% |
| 2019-03-26 | 2019-03-26 | Change Of Name | NA | 0.00% |
Expleo Solutions Competitors Screener - Peer Comparison
Screen EXPLEOSOL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| L&T Technology Services | 35,483 | 28.01 | 10,880 | 10.41% | 1,264 | 50.98 |
| Inventurus Knowledge Solutions | 23,041 | 34.55 | 2,703 | 45.49% | 486 | 43.54 |
| Tata Technologies | 21,968 | 40.55 | 5,293 | 1.14% | 677 | 45.67 |
| Affle 3i | 20,010 | 46.14 | 2,360 | 24.22% | 382 | 51.87 |
| Sagility | 19,535 | 23.05 | 5,626 | 17.67% | 539 | 52.57 |
| Cyient | 8,944 | 14.86 | 7,457 | 3.38% | 648 | 37.57 |
| Black Box | 8,046 | 39.52 | 5,972 | -5.22% | 205 | 41.95 |
| Amagi Media Labs | 6,983 | 265.08 | 1,223 | 29.83% | -69 | 30.46 |
| Axiscades Engineering Technologies | 6,925 | 65.28 | 1,052 | 8.33% | 75 | 66.20 |
| E2E Networks | 4,622 | -528.60 | 203 | 111.65% | 48 | 47.95 |
Expleo Solutions Company Announcements - News Screener
Screen EXPLEOSOL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-06 | Disclosure Under Regulation 30 Read With Clause 20 Para A Of Part A Of Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-04-05 | Closure of Trading Window | - |
| 2026-03-29 | Disclosure Under Regulation 30 Read With Clause 20 Para A Of Part A Of Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-02-18 | Update On Closure Of Competence Centre At Coimbatore Tamil Nadu India | - |
| 2026-02-11 | Disclosure Under Regulation 30 Read With Clause 20 Para A Of Part A Of Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-02-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-02-03 | Financial Results For The Quarter And Nine Months Ended December 31 2025. | - |
| 2026-02-03 | Board Meeting Outcome for For Declaration Of Unaudited (Standalone And Consolidated) Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025. | - |
| 2026-01-30 | Disclosure Under Regulation 30 Read With Sub-Para 8 Of Para B Of Schedule III Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-01-27 | Disclosure Under Regulation 30 Read With Clause 20 Para A Of Part A Of Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-01-27 | Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Month Period Ended December 31 2025. | - |
| 2026-01-23 | Disclosure Under Regulation 30 Read With Clause 20 Para A Of Part A Of Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-01-20 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-01-14 | Disclosure Under Regulation 30 Read With Clause 20 Para A Of Part A Of Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2025-12-30 | Closure of Trading Window | - |
| 2025-12-12 | Announcement under Regulation 30 (LODR)-Resignation of Director | - |
| 2025-11-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |